{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:20:26Z","timestamp":1788272426930,"version":"build-2803163510"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.cimid.2025.102357","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T19:23:10Z","timestamp":1746904990000},"page":"102357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Immunization of BALB\/c mice with detoxified lipopolysaccharide and hydrolytic O-polysaccharide from Brucella melitensis either in combination with or conjugated to tetanus toxoid, enhances protective immune responses against the pathogen"],"prefix":"10.1016","volume":"121","author":[{"given":"Nima","family":"Khoramabadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza Hosseini","family":"Doust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf Mohabati","family":"Mobarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Shapouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cimid.2025.102357_bib1","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1007\/s11259-024-10519-5","article-title":"Molecular epidemiology of brucellosis in Asia: insights from genotyping analyses","volume":"48","author":"Ali","year":"2024","journal-title":"Vet. Res Commun."},{"issue":"2","key":"10.1016\/j.cimid.2025.102357_bib2","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2295398","article-title":"Brucellosis: epidemiology, pathogenesis, diagnosis and treatment-a comprehensive review","volume":"55","author":"Qureshi","year":"2023","journal-title":"Ann. Med"},{"issue":"9","key":"10.1016\/j.cimid.2025.102357_bib3","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3201\/eid2909.230052","article-title":"Global estimate of human brucellosis incidence","volume":"29","author":"Laine","year":"2023","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mib.2004.12.003","article-title":"Brucella lipopolysaccharide acts as a virulence factor","volume":"8","author":"Lapaque","year":"2005","journal-title":"Curr. Opin. Microbiol"},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/21505594.2017.1395544","article-title":"Brucella Lipopolysaccharide and pathogenicity: The core of the matter","volume":"9","author":"Smith","year":"2018","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/01652176.2020.1868616","article-title":"Bovine brucellosis - a comprehensive review","volume":"41","author":"Khurana","year":"2021","journal-title":"Vet. Q"},{"key":"10.1016\/j.cimid.2025.102357_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.micpath.2012.11.011","article-title":"Lipopolysaccharide as a target for brucellosis vaccine design","volume":"58","author":"Conde-Alvarez","year":"2013","journal-title":"Micro Pathog."},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tvjl.2010.07.009","article-title":"Lipopolysaccharide: a complex role in the pathogenesis of brucellosis","volume":"189","author":"Pei","year":"2011","journal-title":"Vet. J."},{"issue":"2","key":"10.1016\/j.cimid.2025.102357_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/157489109788490316","article-title":"Chemical structure and biological significance of lipopolysaccharide from Legionella","volume":"4","author":"Palusinska-Szysz","year":"2009","journal-title":"Recent Pat. anti-Infect. Drug Discov."},{"key":"10.1016\/j.cimid.2025.102357_bib10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.micpath.2018.01.007","article-title":"Comparative experimental study of Brucella melitensis and its lipopolysaccharide in mouse model infected via subcutaneous route of exposure","volume":"116","author":"Osman","year":"2018","journal-title":"Micro Pathog."},{"issue":"4","key":"10.1016\/j.cimid.2025.102357_bib11","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1128\/iai.60.4.1385-1389.1992","article-title":"Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines","volume":"60","author":"Goldstein","year":"1992","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.cimid.2025.102357_bib12","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1128\/iai.63.8.3054-3061.1995","article-title":"The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides","volume":"63","author":"Martinez de Tejada","year":"1995","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.cimid.2025.102357_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002675","article-title":"The Lipopolysaccharide Core of Brucella abortus Acts as a Shield Against Innate Immunity Recognition","volume":"8","author":"Conde-Alvarez","year":"2012","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.cimid.2025.102357_bib14","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1111\/tbed.14259","article-title":"Efficacy of Brucella abortus S19 and RB51 vaccine strains: A systematic review and meta-analysis","volume":"69","author":"de Oliveira","year":"2022","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.cimid.2025.102357_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.903890","article-title":"Evaluation of immune responses to Brucella vaccines in mouse models: a systematic review","volume":"9","author":"Darbandi","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.cimid.2025.102357_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cimid.2019.03.015","article-title":"Immunogenic and protective antigens of Brucella as vaccine candidates","volume":"65","author":"Masjedian Jezi","year":"2019","journal-title":"Comp. Immunol. Microbiol Infect. Dis."},{"issue":"12","key":"10.1016\/j.cimid.2025.102357_bib17","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/nm.2535","article-title":"A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design","volume":"17","author":"Avci","year":"2011","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.cimid.2025.102357_bib18","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1021\/cb400423g","article-title":"Recent mechanistic insights on glycoconjugate vaccines and future perspectives","volume":"8","author":"Berti","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"6","key":"10.1016\/j.cimid.2025.102357_bib19","article-title":"Protein carriers for glycoconjugate vaccines: history, selection criteria, characterization and new trends","volume":"23","author":"Micoli","year":"2018","journal-title":"Mol. (Basel, Switz. )"},{"issue":"3","key":"10.1016\/j.cimid.2025.102357_bib20","article-title":"Host immune responses and pathogenesis to brucella spp. infection","volume":"10","author":"Oliveira","year":"2021","journal-title":"Pathog. (Basel, Switz. )"},{"issue":"5","key":"10.1016\/j.cimid.2025.102357_bib21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/23744235.2019.1568545","article-title":"A review of the immunopathogenesis of Brucellosis","volume":"51","author":"Amjadi","year":"2019","journal-title":"Infect. Dis. (Lond., Engl. )"},{"issue":"2","key":"10.1016\/j.cimid.2025.102357_bib22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.21307\/pjm-2018-029","article-title":"Brucella - Virulence Factors, Pathogenesis and Treatment","volume":"67","author":"G\u0142owacka","year":"2018","journal-title":"Pol. J. Microbiol"},{"key":"10.1016\/j.cimid.2025.102357_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ddtec.2020.11.003","article-title":"Structure-based glycoconjugate vaccine design: The example of Group B Streptococcus type III capsular polysaccharide","volume":"35-36","author":"Carboni","year":"2020","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.cimid.2025.102357_bib24","first-page":"1","article-title":"Group B Streptococcus chimeric capsular polysaccharides as novel multivalent vaccine candidates","author":"Campisi","year":"2021","journal-title":"Glycoconj. J."},{"issue":"6","key":"10.1016\/j.cimid.2025.102357_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002926","article-title":"A protein-conjugate approach to develop a monoclonal antibody-based antigen detection test for the diagnosis of human brucellosis","volume":"8","author":"Patra","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"10","key":"10.1016\/j.cimid.2025.102357_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182452","article-title":"A recombinant O-polysaccharide-protein conjugate approach to develop highly specific monoclonal antibodies to Shiga toxin-producing Escherichia coli O157 and O145 serogroups","volume":"12","author":"Castillo","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib27","first-page":"5","article-title":"Protection of BALB\/C mice against Brucella abortus 544 challenge by vaccination with combination of recombinant human serum albumin-l7\/l12 (Brucella abortus ribosomal protein) and lipopolysaccharide","volume":"69","author":"Pakzad","year":"2010","journal-title":"Roum. Arch. Microbiol Immunol."},{"issue":"8","key":"10.1016\/j.cimid.2025.102357_bib28","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3923\/jbs.2010.767.772","article-title":"Novel approach of vaccination against brucella abortus 544 based on a combination of fusion proteins, human serum albumin and brucella abortus lipopolysaccharides","volume":"10","author":"Pakzad","year":"2010","journal-title":"J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12026-013-8427-6","article-title":"Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A","volume":"58","author":"Romeu","year":"2014","journal-title":"Immunol. Res."},{"issue":"6","key":"10.1016\/j.cimid.2025.102357_bib30","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.4049\/jimmunol.1300722","article-title":"Noncovalent association of protein and capsular polysaccharide on bacteria-sized latex beads as a model for polysaccharide-specific humoral immunity to intact gram-positive extracellular bacteria","volume":"191","author":"Colino","year":"2013","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cimid.2025.102357_bib31","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1128\/IAI.70.7.3324-3329.2002","article-title":"Protection of mice against brucellosis by intranasal immunization with Brucella melitensis lipopolysaccharide as a noncovalent complex with Neisseria meningitidis group B outer membrane protein","volume":"70","author":"Bhattacharjee","year":"2002","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.cimid.2025.102357_bib32","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/infdis\/173.5.1157","article-title":"A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia","volume":"173","author":"Bhattacharjee","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"S1","key":"10.1016\/j.cimid.2025.102357_bib33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4142\/jvs.2017.18.S1.281","article-title":"Development and trial of vaccines against Brucella","volume":"18","author":"Lalsiamthara","year":"2017","journal-title":"J. Vet. Sci."},{"issue":"6","key":"10.1016\/j.cimid.2025.102357_bib34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0923-2508(93)90055-7","article-title":"Monoclonal antibodies to Brucella rough lipopolysaccharide: characterization and evaluation of their protective effect against B. abortus","volume":"144","author":"Cloeckaert","year":"1993","journal-title":"Res Microbiol"},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1099\/00222615-30-1-37","article-title":"Humoral immunity in mice mediated by monoclonal antibodies against the A and M antigens of Brucella","volume":"30","author":"Limet","year":"1989","journal-title":"J. Med Microbiol"},{"issue":"12","key":"10.1016\/j.cimid.2025.102357_bib36","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1128\/iai.56.12.3251-3261.1988","article-title":"Killing of Brucella abortus by bovine serum","volume":"56","author":"Corbeil","year":"1988","journal-title":"Infect. Immun."},{"issue":"55","key":"10.1016\/j.cimid.2025.102357_bib37","first-page":"1","article-title":"Laboratory techniques in brucellosis","author":"Alton","year":"1975","journal-title":"Monogr. Ser. World Health Organ"},{"issue":"4","key":"10.1016\/j.cimid.2025.102357_bib38","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1128\/jb.178.4.1070-1079.1996","article-title":"Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide","volume":"178","author":"Aragon","year":"1996","journal-title":"J. Bacteriol."},{"issue":"7","key":"10.1016\/j.cimid.2025.102357_bib39","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1128\/iai.64.7.2709-2715.1996","article-title":"Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls","volume":"64","author":"Konadu","year":"1996","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cimid.2025.102357_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104396","article-title":"Investigating the role of L. pnuemophila LPS derivatives in formation of specific cell-mediated immune responses against the pathogen","volume":"147","author":"Papian","year":"2020","journal-title":"Micro Pathog."},{"key":"10.1016\/j.cimid.2025.102357_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104364","article-title":"Potent T-cell mediated immune response against Legionella pneumophila in mice following vaccination with detoxified lipopolysaccharide non-covalently combined with recombinant flagellin A and peptidoglycan-associated lipoprotein","volume":"149","author":"Mehdi Abdol","year":"2020","journal-title":"Micro Pathog."},{"issue":"6","key":"10.1016\/j.cimid.2025.102357_bib42","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1128\/IAI.68.6.3210-3218.2000","article-title":"Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance","volume":"68","author":"Velasco","year":"2000","journal-title":"Infect. Immun."},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/21505594.2017.1386831","article-title":"Immunomodulatory properties of Brucella melitensis lipopolysaccharide determinants on mouse dendritic cells in vitro and in vivo","volume":"9","author":"Zhao","year":"2018","journal-title":"Virulence"},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib44","first-page":"284","article-title":"Picogram-sensitive assay for endotoxin","volume":"261","author":"Yin","year":"1972","journal-title":"gelation Limulus polyphemus blood Cell lysate Induc. purified lipopolysaccharides Lipid A Gram. -Negat. Bact. Biochim Biophys. Acta"},{"issue":"3","key":"10.1016\/j.cimid.2025.102357_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.biologicals.2005.04.002","article-title":"Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxide","volume":"33","author":"Park","year":"2005","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.cimid.2025.102357_bib46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/infdis\/148.3.492","article-title":"Electrophoretic heterogeneity and interstrain variation of the lipopolysaccharide of Haemophilus influenzae","volume":"148","author":"Inzana","year":"1983","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0003-2697(82)90673-X","article-title":"A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels","volume":"119","author":"Tsai","year":"1982","journal-title":"Anal. Biochem"},{"issue":"15","key":"10.1016\/j.cimid.2025.102357_bib48","first-page":"4703","article-title":"Studies on the meningococcal polysaccharides","volume":"246","author":"Liu","year":"1971","journal-title":"Ii. Compos. Chem. Prop. Group B Group C. Polysacch. J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.cimid.2025.102357_bib49","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1016\/S0021-9258(19)41784-5","article-title":"Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance","volume":"250","author":"Bhattacharjee","year":"1975","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cimid.2025.102357_bib50","series-title":"Food Analysis Laboratory Manual","first-page":"47","article-title":"Phenol-Sulfuric Acid Method for Total Carbohydrates","author":"Nielsen","year":"2010"},{"key":"10.1016\/j.cimid.2025.102357_bib51","series-title":"Food Analysis Laboratory Manual","first-page":"137","article-title":"Total Carbohydrate by Phenol-Sulfuric Acid Method","author":"Nielsen","year":"2017"},{"issue":"12","key":"10.1016\/j.cimid.2025.102357_bib52","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/0264-410X(91)90010-4","article-title":"Induction of antibody and protective responses in mice by Brucella O-polysaccharide-BSA conjugate","volume":"9","author":"Jacques","year":"1991","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.cimid.2025.102357_bib53","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1128\/iai.60.8.3201-3208.1992","article-title":"Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin","volume":"60","author":"Gupta","year":"1992","journal-title":"Infect. Immun."},{"issue":"46","key":"10.1016\/j.cimid.2025.102357_bib54","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1016\/j.vaccine.2014.08.056","article-title":"Impact of conjugation chemistry on the immunogenicity of S. Typhimurium conjugate vaccines","volume":"32","author":"Stefanetti","year":"2014","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.cimid.2025.102357_bib55","doi-asserted-by":"crossref","first-page":"4450","DOI":"10.1128\/iai.59.12.4450-4458.1991","article-title":"Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid","volume":"59","author":"Chu","year":"1991","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.cimid.2025.102357_bib56","doi-asserted-by":"crossref","first-page":"5048","DOI":"10.1128\/iai.62.11.5048-5054.1994","article-title":"Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines","volume":"62","author":"Konadu","year":"1994","journal-title":"Infect. Immun."},{"issue":"11","key":"10.1016\/j.cimid.2025.102357_bib57","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.1128\/iai.60.11.4679-4686.1992","article-title":"Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine","volume":"60","author":"Watson","year":"1992","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.cimid.2025.102357_bib58","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s12033-013-9696-y","article-title":"A comparative approach to strategies for cloning, expression, and purification of Mycobacterium tuberculosis mycolyl transferase 85B and evaluation of immune responses in BALB\/c mice","volume":"56","author":"Aghababa","year":"2014","journal-title":"Mol. Biotechnol."},{"issue":"10","key":"10.1016\/j.cimid.2025.102357_bib59","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0264-410X(96)00018-7","article-title":"Immunization of mice with recombinant L7\/L12 ribosomal protein confers protection against Brucella abortus infection","volume":"14","author":"Oliveira","year":"1996","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.cimid.2025.102357_bib60","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2006.09.051","article-title":"Immunological responses and protective efficacy against Brucella melitensis induced by bp26 and omp31 B. melitensis Rev.1 deletion mutants in sheep","volume":"25","author":"Jacques","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib61","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+\u2009and CD8+\u2009T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cimid.2025.102357_bib62","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.molimm.2018.10.002","article-title":"Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7\/L12+rTOmp31+rSOmp2b) in two different adjuvant formulations in BALB\/c mice","volume":"103","author":"Golshani","year":"2018","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cimid.2025.102357_bib63","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.molimm.2019.09.013","article-title":"Immunoinformatics prediction of OMP2b and BCSP31 for designing multi-epitope vaccine against Brucella","volume":"114","author":"Li","year":"2019","journal-title":"Mol. Immunol."},{"issue":"8","key":"10.1016\/j.cimid.2025.102357_bib64","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftaa002","article-title":"A combined subunit vaccine comprising BP26, Omp25 and L7\/L12 against brucellosis","volume":"77","author":"Gupta","year":"2019","journal-title":"Pathog. Dis."},{"issue":"2","key":"10.1016\/j.cimid.2025.102357_bib65","article-title":"Simultaneous Immunization with Omp25 and L7\/L12 Provides Protection against Brucellosis in Mice","volume":"9","author":"Gupta","year":"2020","journal-title":"Pathog. (Basel, Switz. )"},{"issue":"7","key":"10.1016\/j.cimid.2025.102357_bib66","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/CVI.00472-06","article-title":"Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting","volume":"14","author":"Cassataro","year":"2007","journal-title":"Clin. Vaccin. Immunol."},{"issue":"2","key":"10.1016\/j.cimid.2025.102357_bib67","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molimm.2015.04.015","article-title":"Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7\/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen","volume":"66","author":"Golshani","year":"2015","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.cimid.2025.102357_bib68","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0264-410X(98)00205-9","article-title":"Immunogenicity of recombinant Escherichia coli expressing the omp31 gene of Brucella melitensis in BALB\/c mice","volume":"17","author":"Guilloteau","year":"1999","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.cimid.2025.102357_bib69","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect. Immun."},{"issue":"4","key":"10.1016\/j.cimid.2025.102357_bib70","first-page":"261","article-title":"Protective efficacy of a Brucella vaccine using a Salmonella-based delivery system expressing Brucella Omp3b, BCSP31, and SOD proteins against brucellosis in Korean black goats","volume":"83","author":"Kim","year":"2019","journal-title":"Can. J. Vet. Res"},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13567-020-0735-y","article-title":"Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7\/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge","volume":"51","author":"Senevirathne","year":"2020","journal-title":"Vet. Res"},{"key":"10.1016\/j.cimid.2025.102357_bib72","article-title":"Recombinant Lactococcus Lactis Displaying Omp31 Antigen of Brucella melitensis Can Induce an Immunogenic Response in BALB\/c Mice","author":"Shirdast","year":"2020","journal-title":"Probiotics Antimicrob. Proteins"},{"issue":"5","key":"10.1016\/j.cimid.2025.102357_bib73","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s11250-018-1517-7","article-title":"Immunogenicity of adenovirus and DNA vaccines co-expressing P39 and lumazine synthase proteins of Brucella abortus in BALB\/c mice","volume":"50","author":"Lin","year":"2018","journal-title":"Trop. Anim. Health Prod."},{"key":"10.1016\/j.cimid.2025.102357_bib74","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-11-69","article-title":"Influenza viral vectors expressing the Brucella OMP16 or L7\/L12 proteins as vaccines against B. abortus infection","volume":"11","author":"Tabynov","year":"2014","journal-title":"Virol. J."},{"key":"10.1016\/j.cimid.2025.102357_bib75","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fvets.2020.00058","article-title":"Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector-Based Brucella abortus Vaccine Against Brucella melitensis Infection in Sheep and Goats","volume":"7","author":"Mailybayeva","year":"2020","journal-title":"Front. Vet. Sci."},{"issue":"14","key":"10.1016\/j.cimid.2025.102357_bib76","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1074\/jbc.M115.701540","article-title":"Structural Studies of Lipopolysaccharide-defective Mutants from Brucella melitensis Identify a Core Oligosaccharide Critical in Virulence","volume":"291","author":"Fontana","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cimid.2025.102357_bib77","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13567-014-0072-0","article-title":"Mutants in the lipopolysaccharide of Brucella ovis are attenuated and protect against B. ovis infection in mice","volume":"45","author":"Soler-Llorens","year":"2014","journal-title":"Vet. Res"},{"issue":"11","key":"10.1016\/j.cimid.2025.102357_bib78","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.vaccine.2015.01.046","article-title":"Structural correlates of carrier protein recognition in tetanus toxoid-conjugated bacterial polysaccharide vaccines","volume":"33","author":"Lockyer","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.cimid.2025.102357_bib79","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev-immunol-030409-101159","article-title":"How bacterial carbohydrates influence the adaptive immune system","volume":"28","author":"Avci","year":"2010","journal-title":"Annu Rev. Immunol."},{"issue":"42","key":"10.1016\/j.cimid.2025.102357_bib80","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1016\/j.vaccine.2017.08.056","article-title":"Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adults","volume":"35","author":"van der Heiden","year":"2017","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.cimid.2025.102357_bib81","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1016\/j.vaccine.2016.06.039","article-title":"Preclinical studies on new proteins as carrier for glycoconjugate vaccines","volume":"34","author":"Tontini","year":"2016","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.cimid.2025.102357_bib82","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1128\/IAI.67.8.4048-4054.1999","article-title":"Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes","volume":"67","author":"Forestier","year":"1999","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.cimid.2025.102357_bib83","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1128\/iai.61.5.1722-1729.1993","article-title":"Lipopolysaccharide from Brucella abortus behaves as a T-cell-independent type 1 carrier in murine antigen-specific antibody responses","volume":"61","author":"Betts","year":"1993","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.cimid.2025.102357_bib84","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1128\/IAI.71.6.3261-3271.2003","article-title":"Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model","volume":"71","author":"Monreal","year":"2003","journal-title":"Infect. Immun."},{"issue":"13","key":"10.1016\/j.cimid.2025.102357_bib85","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.vaccine.2020.02.012","article-title":"Higher mass meningococcal group C-tetanus toxoid vaccines conjugated with carbodiimide correlate with greater immunogenicity","volume":"38","author":"Lockyer","year":"2020","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.cimid.2025.102357_bib86","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1016\/j.vaccine.2017.04.078","article-title":"Polysaccharide conjugate vaccine protein carriers as a \u201cneglected valency\u201d \u2013 Potential and limitations","volume":"35","author":"Br\u00f6ker","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.cimid.2025.102357_bib87","article-title":"Pseudomonas aeruginosa PAO-1 lipopolysaccharide-diphtheria toxoid conjugate vaccine: preparation, characterization and immunogenicity","volume":"8","author":"Najafzadeh","year":"2015","journal-title":"Jundishapur J. Microbiol"},{"issue":"12","key":"10.1016\/j.cimid.2025.102357_bib88","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1021\/acs.accounts.7b00445","article-title":"Brucellosis: improved diagnostics and vaccine insights from synthetic glycans","volume":"50","author":"Bundle","year":"2017","journal-title":"Acc. Chem. Res."},{"issue":"1","key":"10.1016\/j.cimid.2025.102357_bib89","doi-asserted-by":"crossref","first-page":"137","DOI":"10.20506\/rst.32.1.2190","article-title":"Immunity to brucellosis","volume":"32","author":"Skendros","year":"2013","journal-title":"Rev. Sci. Tech."},{"issue":"2","key":"10.1016\/j.cimid.2025.102357_bib90","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.micinf.2010.10.015","article-title":"Cell-mediated immunity in human brucellosis","volume":"13","author":"Skendros","year":"2011","journal-title":"Microbes Infect."},{"key":"10.1016\/j.cimid.2025.102357_bib91","unstructured":"Guide for the Care and Use of Laboratory Animals. 8 ed. Animals NRCUCftUotGftCaUoL, editor: National Academies Press; 2011 2011."}],"container-title":["Comparative Immunology, Microbiology and Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957125000657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147957125000657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T08:53:36Z","timestamp":1762246416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147957125000657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":91,"alternative-id":["S0147957125000657"],"URL":"https:\/\/doi.org\/10.1016\/j.cimid.2025.102357","relation":{},"ISSN":["0147-9571"],"issn-type":[{"value":"0147-9571","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization of BALB\/c mice with detoxified lipopolysaccharide and hydrolytic O-polysaccharide from Brucella melitensis either in combination with or conjugated to tetanus toxoid, enhances protective immune responses against the pathogen","name":"articletitle","label":"Article Title"},{"value":"Comparative Immunology, Microbiology and Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cimid.2025.102357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102357"}}